ERS International Congress 2021: Pulmonary Vascular Disease Assembly Highlights

[ad_1]

This article was originally published here

ERJ Open Res. 2022 May 23;8(2):00665-2021. doi: 10.1183/23120541.00665-2021. eCollection 2022 Apr.

ABSTRACT

This article aims to summarize the latest research presented at the European Respiratory Society (ERS) Virtual International Congress 2021 in the field of pulmonary vascular disease. In light of current guidelines and procedures, knowledge gaps are addressed and the most recent findings on the different forms of pulmonary hypertension as well as key points about pulmonary embolism are discussed. Despite comprehensive coverage of pulmonary embolism guidelines at previous conferences, discussions of controversies in the diagnosis and treatment of this condition in specific cases have been debated and are addressed in the first section of this article. We then report on an interesting pro-con debate about the current classification of pulmonary hypertension. We further report presentations on cluster 3 pulmonary hypertension, with research exploring pathogenesis, phenotyping, diagnosis, and treatment; important contributions on the diagnosis of post-capillary pulmonary hypertension are also included. Finally, we summarize the latest evidence presented on pulmonary vascular disease and COVID-19 and a statement on new Imaging Guidelines for Pulmonary Vascular Disease from the Fleischner Society.

PMID:35615412 | PMC:PMC9125041 | DOI:10.1183/23120541.00665-2021

[ad_2]
Source link

Comments are closed.